Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular and Clinical Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 2049-9450 Online ISSN: 2049-9469
Journal Cover
January-February 2013 Volume 1 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
January-February 2013 Volume 1 Issue 1

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines

  • Authors:
    • Masahito Hagio
    • Yoko Matsuda
    • Taeko Suzuki
    • Toshiyuki Ishiwata
  • View Affiliations / Copyright

    Affiliations: Departments of Pathology and Integrative Oncological Pathology, Nippon Medical School, Tokyo 113-8602, Japan
  • Pages: 83-87
    |
    Published online on: June 8, 2012
       https://doi.org/10.3892/mco.2012.1
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:


Abstract

Nestin, a class VI intermediate filament, is a neuronal stem/progenitor cell marker that is also expressed by various types of cancer, including pancreatic ductal adenocarcinoma (PDAC). We previously detected nestin expression in approximately 30% of PDAC cases, and found that nestin promotes the migration, invasion and metastasis of cells. Findings of recent studies have shown that epithelial mesenchymal transition (EMT) is important in the invasion and migration of cancer. In the present study, we investigated whether an altered nestin expression affected the expression levels of EMT markers in PDAC cells. Two human PDAC cell lines, PK-45H and KLM-1, in which nestin was suppressed and overexpressed, respectively, were used. The expression levels of the EMT-related molecules E-cadherin, Snail, Slug and Twist were analyzed using quantitative RT-PCR. Results showed that E-cadherin expression was decreased in nestin-overexpressed KLM-1 cells, and increased in nestin-suppressed PK-45H cells. Snail gene expression in the PDAC cells was altered concomitantly with the changes in nestin expression, while the Slug gene expression was significantly decreased in nestin-overexpressed KLM-1 cells. The Twist gene expression was below the detection limit in the two PDAC cell lines. The present findings indicated that nestin may be involved in the control of cancer behaviors in PDAC via the modulation of EMT-related molecules.

Introduction

Pancreatic ductal adenocarcinoma (PDAC) is associated with extremely high mortality rates due to rapid progression and high incidences of metastases, peritoneal dissemination and recurrence (1). Therefore, there is an urgent need for new therapeutic strategies that are focused on preventing the invasion and metastasis of pancreatic cancer cells.

Nestin, a class VI intermediate filament, was first described as a neuronal stem/progenitor cell marker that is expressed in progenitor cells of various tissues, including pancreas (2). Lineage-tracing experiments have shown that exocrine cells in the pancreas are derived from nestin-expressing progenitor cells (3–5). An increased nestin expression has been reported in various tumors, including pancreatic cancer (6). Nestin immunoreactivity was found to be present in the cancer cells in approximately 30% of PDAC cases. Moreover, nestin expression in pancreatic cancer cells was found to correlate with nerve invasion and the presence of cancer cells at the tumor resection margins (7). Suppression of the nestin expression was found to inhibit the invasion and migration of PDAC cells in vitro, and inhibit liver metastasis in a xenograft mouse model (8). These findings suggest that nestin is important in the aggressiveness of pancreatic cancer cells.

The epithelial-mesenchymal transition (EMT), in which cells undergo a morphological switch from the epithelial polarized phenotype to the mesenchymal fibroblastoid phenotype, is considered to occur during cancer invasion and metastasis (9). Several distinct traits are conveyed by EMT, including cell motility and invasiveness (10). As a result of EMT, epithelial cells lose their defined cell-cell/cell-substratum contacts and their structural/functional polarity, and become spindle-shaped and morphologically similar to activated fibroblasts (11). At the molecular level, EMT is defined by the loss of cell-cell adhesion molecules (e.g., E-cadherin and ZO-1), downregulation of epithelial differentiation markers (e.g., cytokeratins and E-cadherin), transcriptional induction of mesenchymal markers (e.g., vimentin, fibronectin, and N-cadherin) and the nuclear localization of β-catenin (12). E-cadherin plays a major role in EMT, and the Snail, Twist, and SIP-1/ZEB-2 proteins are all repressors of the gene CDH1 that codes for E-cadherin.

We hypothesized that nestin regulates the migration and invasion of PDAC cells via interactions with EMT factors. In the present study, we modulated the nestin expression in PDAC cells and investigated the corresponding changes in the mRNA and protein levels of major EMT factors.

Materials and methods

Reagents and chemicals

The following reagents and chemicals were purchased: FuGene HD transfection reagent from Roche Diagnostics (Mannheim, Germany); geneticin from Gibco-BRL (Grand Island, NY, USA); pBAsi-hU6 Neo DNA vector and FastPure RNA kit from Takara Bio, Inc. (Tokyo, Japan); pAcGFP1-N1 vector from Clontech Laboratories (Mountain View, CA, USA) and the High Capacity cDNA Reverse Transcription kit. TaqMan Fast Universal PCR Master Mix, and TaqMan Gene Expression Assays for nestin (Hs00707120_s1), E-cadherin (Hs01013953_m1), Snail (Hs00195591_m1), Slug (Hs00950344_m1), Twist (Hs00361186_m1), and 18S rRNA (Hs99999901_s1) were obtained from Applied Biosystems, Inc. (Foster City, CA, USA). Rabbit polyclonal anti-Snail antibody was purchased from Abcam (Cambridge, UK); Alexa 488-labeled goat anti-rabbit IgG antibody was purchased from Invitrogen Life Technologies (Carlsbad, CA, USA); and Vectashield H-1200 containing 4′,6-diamidino-2-phenylindole-2HCl (DAPI) was obtained from Vector Laboratories (Burlingame, CA, USA). All other chemicals and reagents were purchased from Sigma-Aldrich (St. Louis, MO, USA).

Pancreatic cancer cell lines

PK-45H and KLM-1 human pancreatic cancer cells were obtained from the Cell Resource Center for Biomedical Research, Institute of Development, Aging, and Cancer, Tohoku University, Japan. Cells were grown in RPMI-1640 medium containing 10% fetal bovine serum (FBS) at 37°C under a humidified 5% CO2 atmosphere.

Establishment of nestin short hairpin RNA-transfected PK-45H cells

Human nestin short hairpin (sh) RNA was prepared as previously reported (8). PK-45H cells (1×105 cells/well) were plated in 6-well plates and grown in 2 ml RPMI-1640 medium with 10% FBS. Transfections of the nestin shRNA expression and sham vectors were performed using FuGENE HD transfection reagent, according to the manufacturer’s instructions. Independent colonies were isolated by ring cloning, and expanded in 300 μg/ml geneticin. Cell lysates were collected, and nestin mRNA was measured by quantitative RT-PCR (qRT-PCR).

Establishment of nestin-expressed vector-transfected KLM-1 cells

The full-length nestin cDNA fragment was ligated into the pAcGFP1-N1 eukaryotic expression vector as reported in a previous study (8). Transfections with the nestin expression vector (Nes) and the empty vector (Mock) were performed using FuGENE HD transfection reagent. The cells were passaged and cultured with 600 μg/ml geneticin. Independent colonies were isolated by ring cloning and expanded in 300 μg/ml geneticin.

qRT-PCR

Total RNA was extracted from cells and purified with the FastPure RNA kit. One microgram of the total RNA sample was used for reverse transcription (RT) with the High Capacity cDNA Reverse Transcription kit following the manufacturer’s protocol. qRT-PCR for nestin, E-cadherin, Snail, Slug, Twist and 18S rRNA was performed with the StepOnePlus Real-Time PCR System (Applied Biosystems, Inc.) using specific primers and a TaqMan probe. Cycling conditions were as follows: denaturation for 20 sec at 95°C, followed by annealing for 40 cycles of 1 sec at 95°C and a final extension for 20 sec at 60°C. qRT-PCR results were expressed as the ratio of the target to 18S rRNA, the latter serving as an internal standard. Gene expression levels were measured in triplicate.

Immunocytochemistry

Cells were plated in 35-mm glass-bottomed dishes (2×105 cells/dish) and incubated for 72 h at 37°C in a humidified 5% CO2 atmosphere. The cells were fixed in 4% paraformaldehyde solution for 15 min at room temperature, and incubated overnight at 4°C with polyclonal rabbit anti-Snail antibody. Cells were then incubated with Alexa 488-labeled anti-rabbit IgG antibody (1:1000 dilution), and mounted in Vectashield H-1200. Snail protein was visualized using a Digital Eclipse C1 TE2000-E microscope (Nikon Instech Co., Ltd., Tokyo, Japan). Fluorescent images were analyzed using control software EZ-C1 (Nikon). Confocal settings, including the laser power and detector sensitivity, were unchanged during the acquisition of all images.

Statistical analysis

Quantitative data were shown as the mean ± SEM. One-way ANOVA was used to compare data for each shRNA clone separately for the corresponding values for each of two sham clones. P<0.05 was considered to indicate a statistically significant difference with respect to each of the two sham clones. Data for transiently nestin gene-transfected cells and corresponding Mock-transfected cells were assessed by the Student’s t-test. Computations were performed using the Stat View J version 5.0 software package (SAS Institute, Inc., Cary, NC, USA).

Results

Increase and decrease in expression levels of nestin and E-cadherin in PK-45H and KLM-1 cells

Nestin mRNA expression levels in PK-45H and KLM-1 cells were analyzed using qRT-PCR (Fig. 1). In PK-45H cells, nestin shRNA-transfected clones (Sh-7, −8, and −9) exhibited a markedly decreased nestin expression compared with the sham vector-transfected cells (Sc-13 and −17) (Fig. 1A). Sh-7 cells showed the lowest nestin expression, approximately 40% lower than that of Sc-13 cells. By contrast, KLM-1 cells originally expressed low levels of nestin, and nestin-expressed vector-transfected KLM-1 cells (Nes-9 and −12) expressed higher nestin levels than the empty vector-transfected clones (Mock-13 and −24) (Fig. 1B). Nes-12 cells showed the highest nestin expression level, which was approximately eight times the level of Mock-24 cells.

Figure 1

Expression of nestin and E-cadherin mRNAs in PK-45H and KLM-1 cells. (A) Sh clones exhibited a significantly decreased nestin mRNA expression compared with the Sc clones. (B) Nes clones exhibited a significantly increased nestin mRNA expression compared with the Mock clones. (C) Sh clones exhibited a significantly increased E-cadherin mRNA expression compared with the Sc clones. (D) Nes clones exhibited a significantly decreased E-cadherin mRNA expression compared with the Mock clones. *P<0.05.

Furthermore, we examined the expression of EMT markers, including E-cadherin, a major marker for epithelial cells (Fig. 1). The nestin-suppressed PK-45H clones exhibited a markedly increased E-cadherin expression (Fig. 1C). By contrast, the nestin-overexpressed KLM-1 clones showed significantly decreased E-cadherin mRNA levels (Fig. 1D).

mRNA expression and immunostaining of Snail in PK-45H and KLM-1 cells

To investigate whether altered nestin expression levels affected E-cadherin expression through transcriptional factors, we analyzed the expression of Snail, Slug and Twist. However, Twist expression was not high enough to detect, which is consistent with previous findings (13). Suppression of nestin expression significantly decreased the Snail mRNA expression in PK-45H cells compared with that in sham-transfected Sc clones (Fig. 2A). In addition, the Snail protein expression was apparently decreased in the cytoplasm and nucleus of Sh-9 cells (Fig. 2C). By contrast, Snail mRNA expression was significantly higher in the nestin-expressed vector-transfected KLM-1 cells compared to the Mock-transfected cells (Fig. 2B). Similarly, an increased Snail protein expression was detected in these cells (Nes-9 and −12) (Fig. 2D).

Figure 2

Snail expression in PK-45H and KLM-1 cells. (A and C) Sh clones exhibited a significantly decreased (A) Snail mRNA and (C) protein expression compared with the Sc clones. (B and D) Nes clones exhibited a significantly increased (B) Snail mRNA and (D) protein expression compared with teh Mock clones. *P<0.05. (A and B) qRT-PCR. (C and D) Immunocytochemistry: green, Snail; blue, DAPI. Upper panels, image of Snail; lower panels, merged image. Original magnification, ×1000.

mRNA expression of Slug in PK-45H and KLM-1 cells

Slug expression was not significantly different between the Sc and nestin-suppressed Sh PK-45H clones (Fig. 3A). However, the nestin-overexpressed KLM-1 cells showed a significantly decreased Slug mRNA expression (Fig. 3B).

Figure 3

Expression of Slug mRNA in PK-45H and KLM-1 cells. (A) Slug expression was not statistically different between the Sc and Sh clones. (B) Nes clones exhibited a significantly decreased Slug mRNA expression compared with the Mock clones. *P<0.05.

Discussion

The correlation between the cytoskeletal proteins nestin and E-cadherin in cancer cells remains to be elucidated. Thyroid carcinomas exhibit a high nestin expression, while E-cadherin expression is not detected in anaplastic (undifferentiated) carcinoma. By contrast, E-cadherin, but not nestin, is expressed in papillary and follicular carcinomas (14). The association between these proteins in pancreatic cancer has yet to be adequately clarified. Results of our previous study have shown an increased E-cadherin expression in nestin-suppressed PDAC cells (8). Findings of the present study have shown that nestin overexpression induced the E-cadherin expression, strengthening the association between nestin and E-cadherin.

EMT occurs during various developmental processes, such as gastrulation, neural crest migration and heart formation (15–18). EMT is also involved in pathological processes, such as fibrosis and metastasis (19). The molecular mechanisms controlling EMT have only recently begun to emerge, and key roles have been identified for the zinc finger transcription factors Snail (Snail1) and Slug (Snail2) (20,21). In the present study, E-cadherin was negatively correlated with Snail expression, which is consistent with previous reports that indicate Snail is a repressor of E-cadherin and directly regulates E-cadherin expression via the integrin-linked kinase (ILK) pathway (22). We observed that the Snail expression responded to the increase and decrease of nestin, indicating that nestin is closely correlated with EMT and may thus modulate EMT.

Slug was found to behave differently to Snail. In chicks, Slug has been identified in two developmental processes involving EMT, as a key regulator of mesoderm formation and neural crest migration (23). Another study reported differential effects of Snail and Slug in pancreatic cancer, relating to the interplay between Rho signaling and β1-integrin, and leading to differences in cell migration and scattering (24). Our findings suggest that Slug expression is less involved in EMT via the nestin-induced change of E-cadherin. Twist was not detected in this study; however, it may be involved. Twist reportedly may act through a different mechanism compared to Snail and Zeb proteins (25), and immunohistochemical analysis has detected a decreased expression of nuclear Twist in malignant pancreatic epithelium (26).

In conclusion, the results of this study suggest that nestin may modulate the expression of E-cadherin and Snail, thereby affecting the migration and metastasis of pancreatic cancer.

Acknowledgements

The authors thank Dr Z. Naito for his helpful discussion and Ms. K. Kawahara, Mr. Y. Yanagisawa and Ms. Y. Kawamoto (Department of Pathology, Integrative Oncological Pathology) for their excellent technical assistance. This study was supported by a Grant-in-Aid for Young Scientists (A, no. 22689038 to Y. Matsuda and B, no. 24791451 to M. Hagio), a Grant-in-Aid for Challenging Exploratory Research (no. 23650604 to Y. Matsuda) and a Grant-in-Aid for Scientific Research (C, no. 22591531 to T. Ishiwata) from the Japan Society for the Promotion of Sciences. This study was also supported by a grant from the Pancreas Research Foundation of Japan to M. Hagio.

References

1. 

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008.

2. 

Lendahl U, Zimmerman LB and McKay RD: CNS stem cells express a new class of intermediate filament protein. Cell. 60:585–595. 1990.

3. 

Esni F, Stoffers DA, Takeuchi T and Leach SD: Origin of exocrine pancreatic cells from nestin-positive precursors in developing mouse pancreas. Mech Dev. 121:15–25. 2004.

4. 

Delacour A, Nepote V, Trumpp A and Herrera PL: Nestin expression in pancreatic exocrine cell lineages. Mech Dev. 121:3–14. 2004.

5. 

Ishiwata T, Kudo M, Onda M, Fujii T, Teduka K, Suzuki T, Korc M and Naito Z: Defined localization of nestin-expressing cells in L-arginine-induced acute pancreatitis. Pancreas. 32:360–368. 2006.

6. 

Parry S, Savage K, Marchio C and Reis-Filho JS: Nestin is expressed in basal-like and triple negative breast cancers. J Clin Pathol. 61:1045–1050. 2008.

7. 

Carrière C, Seeley ES, Goetze T, Longnecker DS and Korc M: The Nestin progenitor lineage is the compartment of origin for pancreatic intraepithelial neoplasia. Proc Natl Acad Sci USA. 104:4437–4442. 2007.

8. 

Matsuda Y, Naito Z, Kawahara K, Nakazawa N, Korc M and Ishiwata T: Nestin is a novel target for suppressing pancreatic cancer cell migration, invasion and metastasis. Cancer Biol Ther. 11:512–523. 2011.

9. 

Micalizzi DS, Farabaugh SM and Ford HL: Epithelialmesenchymal transition in cancer: parallels between normal development and tumor progression. J Mammary Gland Biol Neoplasia. 15:117–134. 2010.

10. 

Larue L and Bellacosa A: Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 39 kinase/AKT pathways. Oncogene. 24:7443–7454. 2005.

11. 

Hay ED: The mesenchymal cell, its role in the embryo, and the remarkable signaling mechanisms that create it. Dev Dyn. 233:706–720. 2005.

12. 

Casas E, Kim J, Bendesky A, Ohno-Machado L, Wolfe CJ and Yang J: Snail2 is an essential mediator of Twist1-induced epithelial mesenchymal transition and metastasis. Cancer Res. 71:245–254. 2011.

13. 

Hotz B, Arndt M, Dullat S, Bhargava S, Buhr HJ and Hotz HG: Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer. Clin Cancer Res. 13:4769–4776. 2007.

14. 

Liu J and Brown RE: Immunohistochemical detection of epithelialmesenchymal transition associated with stemness phenotype in anaplastic thyroid carcinoma. Int J Clin Exp Pathol. 3:755–762. 2010.

15. 

Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat (Basel). 154:8–20. 1995.

16. 

Birchmeier C, Birchmeier W and Brand-Saberi B: Epithelialmesenchymal transitions in cancer progression. Acta Anat (Basel). 156:217–226. 1996.

17. 

Thiery JP: Epithelial-mesenchymal transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.

18. 

Kalluri R and Neilson EG: Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest. 112:1776–1784. 2003.

19. 

Taylor MA, Parvani JG and Schiemann WP: The pathophysiology of epithelial-mesenchymal transition induced by transforming growth factor-beta in normal and malignant mammary epithelial cells. J Mammary Gland Biol Neoplasia. 15:169–190. 2010.

20. 

Savagner P: Leaving the neighborhood: molecular mechanisms involved during epithelial-mesenchymal transition. Bioessays. 23:912–923. 2001.

21. 

Huber MA, Kraut N and Beug H: Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol. 17:548–558. 2005.

22. 

Schaeffer DF, Assi K, Chan K, Buczkowski AK, Chung SW, Scudamore CH, Weiss A, Salh B and Owen DA: Tumor expression of integrin-linked kinase (ILK) correlates with the expression of the E-cadherin repressor snail: an immunohistochemical study in ductal pancreatic adenocarcinoma. Virchows Arch. 456:261–268. 2010.

23. 

Nieto MA, Sargent MG, Wilkinson DG and Cooke J: Control of cell behavior during vertebrate development by Slug, a zinc finger gene. Science. 264:835–839. 1994.

24. 

Shields MA, Krantz SB, Bentrem DJ, Dangi-Garimella S and Munshi HG: Interplay between β1-integrin and Rho signaling regulates differential scattering and motility of pancreatic cancer cells by snail and Slug proteins. J Biol Chem. 287:6218–6229. 2012.

25. 

Montserrat N, Gallardo A, Escuin D, Catasus L, Prat J, Gutiérrez-Avignó FJ, Peiró G, Barnadas A and Lerma E: Repression of E-cadherin by SNAIL, ZEB1, and TWIST in invasive ductal carcinomas of the breast: a cooperative effort? Hum Pathol. 42:103–110. 2011.

26. 

Cates JM, Byrd RH, Fohn LE, Tatsas AD, Washington MK and Black CC: Epithelial-mesenchymal transition markers in pancreatic ductal adenocarcinoma. Pancreas. 38:e1–e6. 2009.

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Hagio M, Matsuda Y, Suzuki T and Ishiwata T: Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines. Mol Clin Oncol 1: 83-87, 2013.
APA
Hagio, M., Matsuda, Y., Suzuki, T., & Ishiwata, T. (2013). Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines. Molecular and Clinical Oncology, 1, 83-87. https://doi.org/10.3892/mco.2012.1
MLA
Hagio, M., Matsuda, Y., Suzuki, T., Ishiwata, T."Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines". Molecular and Clinical Oncology 1.1 (2013): 83-87.
Chicago
Hagio, M., Matsuda, Y., Suzuki, T., Ishiwata, T."Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines". Molecular and Clinical Oncology 1, no. 1 (2013): 83-87. https://doi.org/10.3892/mco.2012.1
Copy and paste a formatted citation
x
Spandidos Publications style
Hagio M, Matsuda Y, Suzuki T and Ishiwata T: Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines. Mol Clin Oncol 1: 83-87, 2013.
APA
Hagio, M., Matsuda, Y., Suzuki, T., & Ishiwata, T. (2013). Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines. Molecular and Clinical Oncology, 1, 83-87. https://doi.org/10.3892/mco.2012.1
MLA
Hagio, M., Matsuda, Y., Suzuki, T., Ishiwata, T."Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines". Molecular and Clinical Oncology 1.1 (2013): 83-87.
Chicago
Hagio, M., Matsuda, Y., Suzuki, T., Ishiwata, T."Nestin regulates epithelial-mesenchymal transition marker expression in pancreatic ductal adenocarcinoma cell lines". Molecular and Clinical Oncology 1, no. 1 (2013): 83-87. https://doi.org/10.3892/mco.2012.1
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team